subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

subject_name: ONTORPACEPT

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Refractory Grade 3b Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Gray-Zone Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314996

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UMLS:C4086835

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C4086835

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UMLS:C4086835

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: High grade B-cell lymphoma refractory


subject: UMLS:C4086835

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C4086835

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C4086835

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UMLS:C4086835

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C4086835

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UMLS:C4086835

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C4086835

object_name: High grade B-cell lymphoma recurrent


subject: UMLS:C4086835

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UMLS:C4086835

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C4086835

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UMLS:C4086835

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C4086835

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C4086835

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C4086835

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UMLS:C4086835

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C4086835

object_name: B-cell lymphoma recurrent


subject: UMLS:C4086835

object_name: Recurrent Gray-Zone Lymphoma


subject: UMLS:C4086835

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:DPT0O3T46P

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: High grade B-cell lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:DPT0O3T46P

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:DPT0O3T46P

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation


subject: UNII:DPT0O3T46P

object_name: High grade B-cell lymphoma recurrent


subject: UNII:DPT0O3T46P

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:DPT0O3T46P

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:DPT0O3T46P

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:DPT0O3T46P

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:DPT0O3T46P

object_name: Recurrent Gray-Zone Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UMLS:C3266905

object_name: HIV infection


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: acute myocardial infarction

tested_intervention: yes


subject: CHEBI:55340

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:2723635

subject_name: GLUCOSAMINE HYDROCHLORIDE

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:2723635

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:2723635

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:2723635

object_name: obesity


subject: PUBCHEM.COMPOUND:2723635

object_name: Obesity, CTCAE


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: CHEBI:20993


subject: CHEBI:20993


subject: CHEBI:20993


subject: CHEBI:20993


subject: GTOPDB:12652

subject_name: magrolimab

object_name: mycosis fungoides


subject: GTOPDB:12652

object_name: Sezary syndrome


subject: GTOPDB:12652

object_name: Mycosis fungoides refractory


subject: GTOPDB:12652

object_name: Sezary syndrome refractory


subject: GTOPDB:12652

object_name: Mycosis fungoides/Sezary syndrome refractory


subject: GTOPDB:12652

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: GTOPDB:12652

object_name: Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: GTOPDB:12652

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: GTOPDB:12652

object_name: Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: GTOPDB:12652

object_name: Mycosis fungoides recurrent


subject: GTOPDB:12652

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: GTOPDB:12652

object_name: Sezary syndrome recurrent


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:3077

subject_name: Betamethasone

object_name: vestibular disorder


subject: CHEBI:3077

object_name: vestibular neuronitis


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: nephrolithiasis


subject: UMLS:C4086499

subject_name: Huaier Extract Granule


subject: UNII:8S10GFI6DX

subject_name: banlangen

object_name: influenza


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: Cognitive impairment


subject: CHEBI:197268

object_name: diabetic neuropathy


subject: UNII:1W14T9L25W

subject_name: navicixizumab

object_name: Stomach cancer


subject: UNII:1W14T9L25W

object_name: gastric cancer


subject: UNII:1W14T9L25W

object_name: colorectal cancer


subject: UNII:1W14T9L25W

object_name: colorectal carcinoma


subject: UNII:1W14T9L25W

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:1W14T9L25W

object_name: triple-negative breast carcinoma


subject: UNII:1W14T9L25W

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: UMLS:C3896797


subject: CHEBI:45783

subject_name: Imatinib

object_name: adult fibrosarcoma


subject: CHEBI:45783

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C2606557

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C2606557

object_name: pulmonary hypertension


subject: UMLS:C2606557

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C2606557

object_name: pulmonary arterial hypertension


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: thrombocytopenia


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:31401

object_name: Acute Ischemic Stroke


subject: CHEBI:45783

object_name: tuberculosis


subject: UMLS:C3640129

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: regurgitation with acid


subject: CHEBI:50275

object_name: Upper abdominal pain


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:6375


subject: CHEBI:6375

object_name: Nausea, CTCAE_5


subject: CHEBI:6375

object_name: Nausea


subject: CHEBI:6375

object_name: Nausea, CTCAE_3


subject: CHEBI:7915

subject_name: Pantoprazole


subject: CHEBI:7915


subject: CHEBI:7915


subject: CHEBI:7915


subject: CHEBI:7915


subject: HMDB:HMDB0014735

subject_name: Gadoteridol

object_name: High grade glioma


subject: HMDB:HMDB0014735

object_name: malignant glioma


subject: HMDB:HMDB0014735

object_name: Grade III Childhood Astrocytoma


subject: HMDB:HMDB0014735

object_name: Adult Anaplastic Astrocytoma


subject: HMDB:HMDB0014735

object_name: anaplastic astrocytoma


subject: HMDB:HMDB0014735

object_name: glioblastoma


subject: HMDB:HMDB0014735

object_name: Brain Stem Glioblastoma


subject: HMDB:HMDB0014735

object_name: glioma susceptibility 1


subject: HMDB:HMDB0014735

object_name: Childhood Glioblastoma


subject: HMDB:HMDB0014735

object_name: adult glioblastoma


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: CHEBI:31643


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: UMLS:C5446936


subject: CHEBI:44245

subject_name: Menaquinone 7

object_name: carotid artery disorder


subject: CHEBI:44245

object_name: coronary artery disorder


subject: CHEBI:44245

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Non-small cell lung cancer stage III


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: cancer


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: HIV infection


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: secondary sclerosing cholangitis


subject: CHEBI:15379

subject_name: Oxygen

object_name: concussion


subject: CHEBI:15379

object_name: Mild Traumatic Brain Injury


subject: CHEBI:15379

object_name: Depressed mood


subject: CHEBI:15379

object_name: Cancer patients and suicide and depression


subject: CHEBI:15379

object_name: Depressed - symptom


subject: CHEBI:15379

object_name: Depression, CTCAE


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:233309

subject_name: Adagrasib


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: urticaria


subject: UNII:7D0YB67S97

object_name: reported urticaria (physical finding)


subject: UNII:7D0YB67S97

object_name: Urticaria, CTCAE


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:3219

subject_name: Bupropion

object_name: cocaine dependence


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C3641122


subject: CHEBI:74947

subject_name: Thalidomide

object_name: adult hepatocellular carcinoma


subject: CHEBI:74947

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:74947

object_name: advanced adult primary liver cancer


subject: UMLS:C1515367

subject_name: Xerecept

object_name: Peritumoral Brain Edema


subject: CHEBI:133833

subject_name: Benznidazole

object_name: Safety Issues


subject: CHEBI:114785

object_name: acute myelomonocytic leukemia M4


subject: UMLS:C3274549

object_name: prostate carcinoma


subject: UMLS:C3274549

object_name: prostate cancer


subject: UMLS:C3274549

object_name: prostate neoplasm


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: Leukemia (both ALL and AML)


subject: CHEBI:4031

object_name: myelodysplastic syndrome with excess blasts-1


subject: CHEBI:8802

subject_name: Remifentanil

object_name: hypertension


subject: CHEBI:8802

object_name: Hypertension, CTCAE


subject: CHEBI:8802

object_name: Tachycardia by ECG Finding


subject: CHEBI:8802

object_name: Tachycardia


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: diffuse type adenocarcinoma


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: PUBCHEM.COMPOUND:22902865

subject_name: Bevirimat

object_name: HIV-1 infection


subject: CHEBI:16899

subject_name: Mannitol

object_name: Diabetic peripheral neuropathy


subject: CHEBI:9123

subject_name: Sertraline

object_name: Depression, psychotic


subject: CHEBI:9123

object_name: Severe major depression with psychotic features


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Breast cancer stage II


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: malignant neoplasm of breast stage I


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Carcinoma breast stage I


subject: UNII:6XC1PAD3KF

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:6XC1PAD3KF

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IIIB Breast Carcinoma


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:6XC1PAD3KF

object_name: Stage IIIA Breast Carcinoma


subject: UNII:6XC1PAD3KF

object_name: ductal breast carcinoma in situ


subject: CHEBI:46557

subject_name: Zoledronic acid

object_name: Breast cancer stage II


subject: CHEBI:46557

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:46557

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: malignant neoplasm of breast stage I


subject: CHEBI:46557

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Carcinoma breast stage I


subject: CHEBI:46557

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:46557

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:46557

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:46557

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:46557

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:46557

object_name: ductal breast carcinoma in situ


subject: UMLS:C5245075

subject_name: sea buckthorn oil

object_name: moisture of mucous membranes (physical finding)


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Stomach Ulcer, CTCAE


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Brain fog


subject: UMLS:C3827121

object_name: cancer


subject: UMLS:C3827121

object_name: neoplasm


subject: UMLS:C4722533

subject_name: ProCervix

object_name: Human Papilloma Virus, Female


subject: UMLS:C4722533

object_name: Human Papilloma Virus, Male


subject: UMLS:C4722533

object_name: Genital infection viral


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:32682

subject_name: L-argininium

object_name: cystic fibrosis


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Trapeziometacarpal osteoarthritis


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: Enterostomy (morphologic abnormality)


subject: CHEBI:33283

subject_name: THIAMINE

object_name: Hyperlactatemia


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: CHEBI:6121

subject_name: Ketamine

object_name: Advanced cancer


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:93775

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:93775

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: pancreatic adenocarcinoma


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Acute appendicitis NOS (disorder)


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: pneumonia


subject: UMLS:C0936150

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:9241

subject_name: Spironolactone

object_name: arrhythmogenic right ventricular cardiomyopathy


subject: UMLS:C1874271

subject_name: ANTIBACTERIAL,TOPICAL

object_name: chronic rhinosinusitis


subject: UMLS:C1550506

subject_name: product - ParticipationType


subject: GTOPDB:13402

subject_name: garadacimab


subject: UNII:32W6AJL0DY

subject_name: GARADACIMAB


subject: UMLS:C5238067

subject_name: Garadacimab


subject: CHEBI:92511

subject_name: Ketotifen

object_name: Childhood Breast Carcinoma


subject: CHEBI:92511

object_name: breast carcinoma


subject: CHEBI:92511

object_name: breast cancer


subject: CHEBI:73579

subject_name: Leu-Val

object_name: Coronavinae infectious disease


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: UMLS:C0759338

object_name: glioblastoma


subject: UMLS:C0759338

object_name: Brain Stem Glioblastoma


subject: UMLS:C0759338

object_name: glioma susceptibility 1


subject: CHEBI:133008

subject_name: Epclusa

object_name: Drug usage


subject: CHEBI:133008

object_name: Drug use history


subject: CHEBI:133008

object_name: Encounter due to drug use


subject: RXCUI:1799208

subject_name: sofosbuvir / velpatasvir Oral Product


subject: RXCUI:1799208


subject: RXCUI:1799208


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: renal carcinoma


subject: UNII:KXG2PJ551I

object_name: kidney neoplasm


subject: UNII:KXG2PJ551I

object_name: refractory cytopenia of childhood


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:38940

subject_name: Sunitinib


subject: MESH:D009822

subject_name: Oils, Volatile


subject: CHEBI:83630

subject_name: essential oil


subject: UMLS:C4744839

subject_name: Pharmacological Ascorbate

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4744839

object_name: acute myeloid leukemia


subject: UMLS:C5937792

subject_name: avibactam / aztreonam

object_name: kidney failure


subject: CHEBI:42797

subject_name: Gabapentin

object_name: anxiety


subject: CHEBI:42797

object_name: Anxiety symptoms


subject: CHEBI:42797

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:42797

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C3537198

subject_name: Human Serum Albumin [EPC]

object_name: Hepatic ascites


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Hormone receptor positive tumor


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: periodontal disorder


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: amphetamine abuse


subject: MESH:D056692

subject_name: Prebiotics

object_name: Allergy


subject: CHEBI:42797

object_name: neoplasm of cerebral hemisphere


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: Mycobacterium avium complex disease


subject: PR:000016619

subject_name: trafficking protein particle complex subunit 9

object_name: helminthiasis


subject: PR:000008994

subject_name: interleukin-1 receptor-like 1


subject: PR:000003595

subject_name: 3-ketoacyl-CoA thiolase, mitochondrial


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: CHEBI:18258

subject_name: Liothyronine


subject: UMLS:C2936843

subject_name: l-Triiodothyronine [EPC]


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:9296

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:9296

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:12358972

subject_name: Dexmecamylamine

object_name: Urinary Urgency


subject: UNII:5Y1141YI4U

subject_name: DEXMECAMYLAMINE


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19

object_name: Chronic liver disease


subject: UMLS:C5383286


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: DRUGBANK:DB15806

subject_name: CoronaVac


subject: CHEBI:3509

object_name: Febrile Neutropenia


subject: CHEBI:3509

object_name: acute lymphoblastic leukemia


subject: CHEBI:3509

object_name: acute myeloid leukemia with minimal differentiation


subject: CHEBI:3509

object_name: acute myeloid leukemia


subject: CHEBI:3509

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: Myelodysplasia


subject: UMLS:C0591457

subject_name: Erwinase


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:63451

subject_name: Infigratinib

object_name: renal pelvis/ureter urothelial carcinoma


subject: UNII:CRR8E37XOB

object_name: Neck Carcinoma


subject: UNII:CRR8E37XOB

object_name: head and neck neoplasm


subject: UNII:CRR8E37XOB

object_name: head and neck cancer


subject: UMLS:C1569206


subject: UMLS:C1569206


subject: UMLS:C1569206


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Opioid withdrawal


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:75179

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:75179

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:75179

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEBI:75179

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:75179

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:90879

subject_name: Tipiracil

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:90879

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:90879

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90879

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEBI:90879

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:90879

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:114785

subject_name: Erlotinib

object_name: exanthem


subject: CHEBI:114785

object_name: Eruptions


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: PUBCHEM.COMPOUND:54675783


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: squamous cell carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:80165

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:80165

object_name: Fatty Liver


subject: CHEBI:80165


subject: UMLS:C0061359

subject_name: glucagon-like peptide 1 (7-36)amide


subject: UMLS:C0061359


subject: UMLS:C0061359


subject: UMLS:C0061359

object_name: type 2 diabetes mellitus


subject: CHEBI:681848

subject_name: Doxapram

object_name: apnea of prematurity


subject: CHEBI:681848

object_name: respiratory failure


subject: CHEBI:681848

object_name: bronchopulmonary dysplasia


subject: CHEBI:681848

object_name: Respiratory insufficiency


subject: CHEBI:9168

subject_name: Sirolimus

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C5441924

object_name: Diabetic Neuralgia


subject: RXCUI:393355

subject_name: betamethasone / calcipotriene Topical Ointment

object_name: Chronic small plaque psoriasis


subject: CHEBI:9144

subject_name: Silibinin

object_name: atrial fibrillation new onset


subject: CHEBI:125451

subject_name: silymarin


subject: MESH:C000722356


subject: PR:000014047

subject_name: eosinophil cationic protein

object_name: graft versus host disease


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Abdominal pain


subject: UMLS:C0360094

object_name: Abdominal Pain, CTCAE


subject: UMLS:C0360094

object_name: Renal Colic, CTCAE


subject: UMLS:C0360094

object_name: renal colic


subject: CHEBI:76018

subject_name: Riociguat

object_name: Common Migraine


subject: UMLS:C2717562


subject: UNII:8F5X4B082E

subject_name: Lixivaptan

object_name: polycystic kidney disease


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: ischemic cardiomyopathy


subject: UMLS:C1099192


subject: CHEBI:139072

object_name: Cognitive changes


subject: CHEBI:139072

object_name: Mood Lability


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: UMLS:C4541385

subject_name: Heplisav-B

object_name: HIV infection


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: female infertility


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives


subject: UMLS:C0591307

subject_name: cyclo-progynova


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0591419

subject_name: Duphaston


subject: CHEBI:31527

subject_name: Dydrogesterone


subject: UMLS:C0018061

subject_name: Gonadotropins


subject: UMLS:C3536870

subject_name: Gonadotropin [EPC]


subject: CHEBI:31401

subject_name: Cilostazol

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: CHEBI:204928

subject_name: Cefotaxime

object_name: Primary bacterial peritonitis


subject: CHEBI:204928

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Myelodysplasia


subject: CHEBI:79699

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:79699

object_name: childhood myelodysplastic syndrome


subject: CHEBI:79699

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:760I9WM792

subject_name: Lasmiditan

object_name: Migraine with or without aura


subject: UMLS:C3253111

object_name: neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: brain cancer


subject: CHEBI:8228

object_name: benign neoplasm of brain


subject: CHEBI:8228

object_name: glioblastoma


subject: CHEBI:8228

object_name: Brain Stem Glioblastoma


subject: CHEBI:8228

object_name: glioma susceptibility 1


subject: CHEBI:8228

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:8228

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:8228

object_name: anaplastic astrocytoma


subject: CHEBI:8228

object_name: anaplastic meningioma


subject: CHEBI:5523

subject_name: Goserelin

object_name: cancer


subject: CHEBI:5523


subject: CHEBI:5523

object_name: prostate neoplasm


subject: CHEBI:521033

subject_name: Dutasteride


subject: CHEBI:521033


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: glucose intolerance


subject: CHEBI:135285

object_name: Impaired glucose tolerance


subject: GTOPDB:12990

subject_name: sintilimab

object_name: bilateral multicystic dysplastic kidney


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:9112

subject_name: sennoside A

object_name: Complication of peritoneal dialysis


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE


subject: UNII:9U7D5QH5AE


subject: CHEBI:30742

subject_name: macrogol


subject: PR:000012224

subject_name: glycodelin


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: cervical cancer


subject: UMLS:C5667079

object_name: cervical carcinoma


subject: UMLS:C5555042

subject_name: Danvilostomig


subject: UMLS:C5555042


subject: UMLS:C5772693

object_name: Deep mycosis


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: thrombocytopenia


subject: CHEBI:49140

object_name: Superficial femoral artery stenosis


subject: CHEBI:49140

object_name: peripheral vascular disease


subject: CHEBI:49140

object_name: peripheral arterial disease


subject: CHEBI:49140

object_name: Iliac artery disease


subject: CHEBI:49140

object_name: Vascular calcification


subject: CHEBI:49140

object_name: intermittent vascular claudication


subject: CHEBI:49140

object_name: Pad Mass


subject: CHEBI:49140

object_name: Claudication


subject: CHEBI:49140

object_name: Antalgic gait


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:3535

subject_name: Cephalexin

object_name: Soft Tissue Infection


subject: CHEBI:3534


subject: PUBCHEM.COMPOUND:167713195

subject_name: leritrelvir

object_name: kidney failure


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: stroke disorder


subject: CHEBI:177504

object_name: cerebrovascular disorder


subject: CHEBI:177504

object_name: Stroke (heart beat)


subject: CHEBI:177504

object_name: Stroke, CTCAE


subject: CHEBI:177504

object_name: brain ischemia


subject: CHEBI:177504

object_name: CNS disorder


subject: CHEBI:177504

object_name: brain infarction


subject: CHEBI:177504

object_name: cerebral infarction


subject: CHEBI:177504

object_name: nervous system disorder


subject: CHEBI:177504

object_name: aneurysm


subject: CHEBI:49868

object_name: pancreatic neoplasm


subject: CHEBI:233413

subject_name: Denifanstat

object_name: colon carcinoma


subject: CHEBI:233413

object_name: colorectal cancer


subject: CHEBI:233413

object_name: colon cancer


subject: MESH:C000717092


subject: MESH:C000717092


subject: MESH:C000717092


subject: CHEBI:66903

subject_name: Vismodegib

object_name: prostate adenocarcinoma


subject: CHEBI:66903

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:66903

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Sepsis with cutaneous manifestations


subject: CHEBI:9753

subject_name: Troglitazone

object_name: malignant soft tissue neoplasm


subject: CHEBI:9753

object_name: sarcoma


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: immunodeficiency disease


subject: CHEBI:36467

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:36467

object_name: myoclonic dystonia 11


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: UniProtKB:P41416


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C0004149

object_name: Myelodysplasia


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0700805

subject_name: Fludara


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C4722471

object_name: Renal cell carcinoma recurrent


subject: CHEBI:9605

subject_name: Tirofiban

object_name: Branch atheromatous disease


subject: UNII:45KLN7N6UV

subject_name: VUSOLIMOGENE ODERPAREPVEC

object_name: melanoma


subject: CHEBI:36791

subject_name: Escitalopram

object_name: traumatic brain injury


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3724

subject_name: citalopram hydrobromide

object_name: traumatic encephalopathy


subject: CHEBI:3724


subject: CHEBI:3724

object_name: Depressed mood


subject: CHEBI:3724

object_name: Cancer patients and suicide and depression


subject: CHEBI:3724

object_name: Depressed - symptom


subject: CHEBI:3724

object_name: Depression, CTCAE


subject: UNII:OJE5810C4F

subject_name: Taxoprexin


subject: UMLS:C1135143


subject: UMLS:C5964773

subject_name: Toll-like Receptor 7/8 Agonist EIK1001

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: aids with tuberculosis


subject: CHEBI:135117

subject_name: ftivazide


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:4877

subject_name: Ethambutol


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:44915

subject_name: Propofol

object_name: Delayed Graft Function


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:27504

subject_name: Mitomycin

object_name: Urothelial carcinoma recurrent


subject: CHEBI:27504

object_name: Urothelial carcinoma ureter recurrent


subject: CHEBI:27504

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:25357

subject_name: mitomycin

object_name: urothelial carcinoma


subject: CHEBI:25357

object_name: transitional cell carcinoma


subject: CHEBI:25357

object_name: renal pelvis urothelial carcinoma


subject: CHEBI:25357

object_name: ureter transitional cell carcinoma


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:18385

subject_name: Thiamine

object_name: pregnancy related


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:50692

subject_name: Mifepristone

object_name: endometrial cancer


subject: CHEBI:50692

object_name: uterine corpus cancer


subject: CHEBI:50692

object_name: endometrial carcinoma


subject: UMLS:C3852521

subject_name: AMG 232

object_name: melanoma


subject: UMLS:C1135138


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: myofascial pain syndrome


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: adult acute myeloid leukemia


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: breast cancer


subject: PUBCHEM.COMPOUND:5281767

object_name: Joint Pain, CTCAE


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Renal Colic, CTCAE


subject: UMLS:C0445115

object_name: renal colic


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: traumatic encephalopathy


subject: CHEBI:201431

object_name: traumatic brain injury


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Advanced cancer


subject: CHEBI:64310

subject_name: Crizotinib


subject: UMLS:C5433280

object_name: pulmonary hypertension


subject: CHEBI:93772

subject_name: Ispinesib

object_name: breast neoplasm


subject: UNII:59WCJ0YNWM

subject_name: Idalopirdine

object_name: Alzheimer disease


subject: CHEBI:60791

subject_name: Xylocard

object_name: Acute Pain


subject: UNII:MC4B01024K

subject_name: CRENOLANIB BESYLATE

object_name: FLT3 Internal Tandem Duplication


subject: UNII:MC4B01024K

object_name: FLT3 Activation Loop Mutation


subject: UNII:MC4B01024K

object_name: PDGFRA Gene Amplification


subject: UNII:MC4B01024K


subject: UMLS:C3827141

subject_name: Crenolanib Besylate


subject: UMLS:C3827141


subject: UMLS:C3827141


subject: UMLS:C3827141


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: thrombocytopenia


subject: PUBCHEM.COMPOUND:11306691

object_name: autoimmune thrombocytopenia


subject: PUBCHEM.COMPOUND:11306691

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:11306691

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:11306691

object_name: blood coagulation disease


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: thyroid tumor


subject: CHEBI:150712

object_name: thyroid gland carcinoma


subject: CHEBI:150712

object_name: thyroid cancer


subject: CHEBI:150712

object_name: goiter


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:133630

subject_name: His-Ala


subject: CHEBI:133630


subject: CHEBI:133630


subject: CHEBI:133630


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: CHEMBL.COMPOUND:CHEMBL2109010

subject_name: CELLULOSE, OXIDIZED REGENERATED


subject: CHEMBL.COMPOUND:CHEMBL2109010


subject: CHEMBL.COMPOUND:CHEMBL2109010


subject: CHEMBL.COMPOUND:CHEMBL2109010


subject: CHEBI:176839

subject_name: vitamin B3

object_name: ataxia telangiectasia


subject: CHEBI:176839

object_name: ATM Gene Mutation


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain

object_name: Intestinal Failure


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Effects of chemotherapy


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate


subject: CHEBI:33569

subject_name: noradrenaline

object_name: effects of; anesthesia, in labor and delivery


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:8093

subject_name: Phenylephrine


subject: MESH:C016752

subject_name: smecta

object_name: acute diarrhea


subject: UMLS:C5963673

subject_name: WHG 626

object_name: plasma cell myeloma


subject: UMLS:C5557202

subject_name: Anti-BCMA/Anti-CD3 Bispecific Antibody WVT078


subject: CHEBI:9168

subject_name: Sirolimus

object_name: lupus nephritis


subject: CHEBI:9907

subject_name: ursodiol

object_name: liver cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL4298015

object_name: Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL4298015

object_name: mild neurocognitive disorder


subject: CHEMBL.COMPOUND:CHEMBL4298015

object_name: mild cognitive impairment


subject: GTOPDB:6932

subject_name: solanezumab


subject: GTOPDB:6932


subject: CHEMBL.COMPOUND:CHEMBL1743072

subject_name: SOLANEZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743072


subject: UMLS:C2935150


subject: UMLS:C2935150


subject: UMLS:C5557271

subject_name: Nicotine Oral Pouch

object_name: Cigarette Smoking-Related Carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Injuries, Acute Brain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:152165

object_name: Soft Tissue Injuries


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:4466

object_name: cholecystitis


subject: UNII:7N8K34P2XH


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C5554545

subject_name: ERK1/2 Inhibitor ERAS-007

object_name: metastatic colorectal cancer


subject: UMLS:C5554545

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: CHEBI:85993

subject_name: Palbociclib


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: sickle cell disease


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: thrombocytopenic purpura


subject: CHEBI:31684

subject_name: Ibudilast

object_name: Medication overuse headache


subject: CHEBI:31684

object_name: Analgesic Overuse Headache


subject: UNII:9D6YZ105SN

subject_name: ornithine phenylacetate

object_name: Acute liver injury


subject: UNII:9D6YZ105SN

object_name: acute liver failure


subject: UMLS:C3492240


subject: UMLS:C3492240


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:63605

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:63605

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Renal rickets


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU

object_name: secondary hyperparathyroidism


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: Diabetes


subject: CHEBI:189965

object_name: diabetes mellitus


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: CHEBI:77148

subject_name: Ginsenoside B2

object_name: type 2 diabetes mellitus


subject: CHEBI:77148


subject: CHEBI:77148


subject: CHEBI:71204

subject_name: bepotastine

object_name: Cough


subject: CHEBI:71204

object_name: Cough, CTCAE


subject: CHEBI:71204

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:31355

subject_name: Carboplatin

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:31355

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:31355

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:31355

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:31355

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:31355

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:31355

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:31355

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:31355

object_name: tongue cancer


subject: CHEBI:31355

object_name: tongue carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:57986

object_name: brittle cornea syndrome 1


subject: CHEBI:57986

object_name: brittle cornea syndrome


subject: CHEBI:57986

object_name: Nevo syndrome


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:32599

object_name: Dysesthesia


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: lung cancer


subject: UNII:37CQ2C7X93

object_name: lung neoplasm


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C5785354

subject_name: CXCR4 Inhibitor GPC-100

object_name: plasma cell myeloma


subject: CHEBI:15365

subject_name: Aspirin

object_name: Hypertension stage 1


subject: CHEBI:15365

object_name: hypertension


subject: UNII:IKE1P4X57J

subject_name: Aggrastat

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:9605

subject_name: Tirofiban


subject: CHEBI:151315

subject_name: Heparin

object_name: Cirrhosis


subject: CHEBI:151315

object_name: liver cirrhosis


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: portal vein thrombosis


subject: UNII:E47C0NF7LV

object_name: Portal Vein Thrombosis, CTCAE


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Complication of anesthesia


subject: CHEBI:49956

subject_name: Xenon

object_name: Acute pulmonary embolism


subject: CHEBI:49956

object_name: chronic thromboembolic pulmonary hypertension


subject: CHEBI:49956

object_name: polycythemia


subject: CHEBI:49956

object_name: Dyspnea


subject: CHEBI:49956

object_name: Dyspnea, CTCAE


subject: CHEBI:49956

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:49956

object_name: anemia


subject: CHEBI:49956

object_name: Anemia, CTCAE


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: adult lymphoma


subject: UMLS:C2346821

object_name: lymphoma


subject: UMLS:C2346821

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: primary central nervous system lymphoma


subject: GTOPDB:11773

subject_name: lepunafusp alfa

object_name: mucopolysaccharidosis type 1


subject: UNII:529C45O9XV

subject_name: LEPUNAFUSP ALFA


subject: UMLS:C5669631

subject_name: Lepunafusp alfa


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Broncho-esophageal fistula


subject: CHEBI:5103

object_name: General anesthetic drug adverse reaction


subject: CHEBI:5103

object_name: Endobronchial metastases


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: PUBCHEM.COMPOUND:9824461


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3641122


subject: UNII:K5CXA4X5U8

subject_name: relmacabtagene autoleucel

object_name: diffuse large B-cell lymphoma


subject: UNII:K5CXA4X5U8

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:K5CXA4X5U8

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C4086713


subject: UMLS:C3659013

object_name: transient ischemic attack


subject: PUBCHEM.COMPOUND:10065020

subject_name: Traxoprodil

object_name: Parkinson disease


subject: DRUGBANK:DB18795


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: High Risk Neuroblastoma


subject: PR:000001379


subject: CHEBI:6067

subject_name: Isotretinoin


subject: PUBCHEM.COMPOUND:2269

object_name: bronchiolitis


subject: PUBCHEM.COMPOUND:2269

object_name: respiratory syncytial virus bronchiolitis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:86285

object_name: Acute nontraumatic kidney injury


subject: PUBCHEM.COMPOUND:53394576


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: myeloproliferative neoplasm


subject: CHEBI:64153

object_name: Non-Cancer Diagnosis


subject: CHEBI:64153

object_name: precancerous condition


subject: CHEBI:64153

object_name: leukemia


subject: CHEBI:64153

object_name: childhood leukemia


subject: CHEBI:64153

object_name: adult lymphoma


subject: CHEBI:64153

object_name: lymphoma


subject: CHEBI:64153

object_name: pediatric lymphoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:28870

object_name: brain neoplasm


subject: UMLS:C4722700

object_name: small cell lung carcinoma


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: Migraine with or without aura


subject: CHEBI:76842

object_name: Infection of musculoskeletal system


subject: CHEBI:28001

subject_name: Vancomycin


subject: GTOPDB:9132

subject_name: vanucizumab

object_name: colorectal cancer


subject: GTOPDB:9132

object_name: colorectal carcinoma


subject: GTOPDB:9132

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL3545259

subject_name: VANUCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545259


subject: CHEMBL.COMPOUND:CHEMBL3545259


subject: UMLS:C3896777


subject: UMLS:C3896777


subject: UMLS:C3896777


subject: CHEBI:24859

subject_name: iodine atom

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:24859

object_name: clear cell renal carcinoma


subject: CHEBI:24859

object_name: renal cell adenocarcinoma


subject: CHEBI:24859

object_name: renal cell carcinoma


subject: CHEBI:24859

object_name: renal carcinoma


subject: CHEBI:24859

object_name: kidney neoplasm


subject: CHEBI:24859

object_name: kidney cancer


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: CHEBI:17606


subject: CHEBI:17606


subject: CHEBI:17606


subject: CHEBI:17606


subject: CHEBI:17606


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: UMLS:C0885449


subject: MESH:C000614959


subject: MESH:C000614959


subject: MESH:C000614959


subject: MESH:C000614959


subject: MESH:C000614959


subject: MESH:C000614959


subject: MESH:C000614959


subject: GTOPDB:7987

subject_name: girentuximab


subject: GTOPDB:7987


subject: GTOPDB:7987


subject: GTOPDB:7987


subject: GTOPDB:7987


subject: GTOPDB:7987


subject: GTOPDB:7987


subject: UNII:539B57DFJF

subject_name: GIRENTUXIMAB


subject: UNII:539B57DFJF


subject: UNII:539B57DFJF


subject: UNII:539B57DFJF


subject: UNII:539B57DFJF


subject: UNII:539B57DFJF


subject: UNII:539B57DFJF


subject: UMLS:C0540128

subject_name: Rencarex


subject: UMLS:C0540128


subject: UMLS:C0540128


subject: UMLS:C0540128


subject: UMLS:C0540128


subject: UMLS:C0540128


subject: UMLS:C0540128


subject: CHEBI:124965

subject_name: Opaganib

object_name: prostate carcinoma


subject: CHEBI:124965

object_name: prostate cancer


subject: UMLS:C2933331

subject_name: Yeliva


subject: UMLS:C2933331


subject: CHEBI:74076

subject_name: Ile-Pro

object_name: malignant epithelial tumor of ovary


subject: CHEBI:82335


subject: CHEBI:17660

subject_name: ENADENINE


subject: UMLS:C4049997


subject: PR:000014564

subject_name: succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:435949

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: UNII:D07V79Q44T

object_name: leukemia


subject: UNII:D07V79Q44T

object_name: childhood leukemia


subject: UNII:D07V79Q44T

object_name: adult lymphoma


subject: UNII:D07V79Q44T

object_name: lymphoma


subject: UNII:D07V79Q44T

object_name: pediatric lymphoma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Android obesity


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: neuroendocrine neoplasm


subject: MESH:C520255

object_name: small cell carcinoma


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC

object_name: small cell lung carcinoma


subject: UNII:7RPW6SU9SC

object_name: non-small cell lung carcinoma


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC


subject: CHEBI:29108

subject_name: Calcium cation

object_name: Community-Acquired Pneumonia


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C0935694

subject_name: Carmustine in Ethanol

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0935694

object_name: Embolism, Tumor


subject: UMLS:C0935694

object_name: Neoplasm Metastasis


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:192614

object_name: Dysmenorrhea


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9434

subject_name: Telmisartan

object_name: hypertriglyceridemia


subject: CHEBI:9434

object_name: Hypertriglyceridemia, CTCAE


subject: PUBCHEM.COMPOUND:164938183

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:21865528

object_name: Aspirin-induced asthma


subject: PUBCHEM.COMPOUND:21865528

object_name: Aspirin-sensitive asthma with nasal polyps


subject: PUBCHEM.COMPOUND:21865528

object_name: Nasal Polyp


subject: CHEBI:188730

subject_name: Ifetroban


subject: CHEBI:188730


subject: CHEBI:188730


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: malnutrition


subject: PUBCHEM.COMPOUND:10207484

subject_name: Custodiol

object_name: Aortic Aneurysm, Thoracoabdominal


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: cancer


subject: UMLS:C4745070

object_name: neoplasm


subject: UMLS:C4745070

object_name: Multiple malignancy


subject: UMLS:C4745070

object_name: malignant glioma


subject: UMLS:C4745070

object_name: bone cancer


subject: UMLS:C4745070

object_name: renal carcinoma


subject: UMLS:C4745070

object_name: kidney cancer


subject: UMLS:C4745070

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C4745070

object_name: pancreatic neoplasm


subject: UMLS:C4745070

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4745070

object_name: malignant pancreatic neoplasm


subject: UMLS:C4745070

object_name: bone neoplasm


subject: UMLS:C4745070

object_name: lung neoplasm


subject: UMLS:C4745070

object_name: breast neoplasm


subject: UMLS:C4745070

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C4745070

object_name: malignant soft tissue neoplasm


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:6520

subject_name: Lomustine

object_name: refractory malignant neoplasm


subject: CHEBI:6520

object_name: cancer


subject: CHEBI:6520


subject: CHEBI:6520

object_name: Refractory Neoplasm


subject: CHEBI:6520


subject: CHEBI:6520

object_name: Osteosarcoma


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520

object_name: pancreatic adenocarcinoma


subject: CHEBI:6520

object_name: Neoplasm Metastasis


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520

object_name: sarcoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255

object_name: Multiple malignancy


subject: MESH:C520255

object_name: malignant glioma


subject: MESH:C520255


subject: MESH:C520255

object_name: bone cancer


subject: MESH:C520255

object_name: renal carcinoma


subject: MESH:C520255

object_name: kidney cancer


subject: MESH:C520255

object_name: Non-Hodgkin's lymphoma refractory


subject: MESH:C520255

object_name: bone neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:27470

subject_name: Folic acid

object_name: substance abuse


subject: CHEBI:27470

object_name: Genotoxicity


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:85196

subject_name: peramivir hydrate

object_name: Nasal Congestion, CTCAE


subject: CHEBI:85196

object_name: Nasal congestion


subject: CHEBI:85196

object_name: pharyngitis


subject: CHEBI:85196

object_name: Pharyngalgia


subject: CHEBI:85196

object_name: Sore Throat, CTCAE


subject: CHEBI:85196

object_name: Headache


subject: CHEBI:85196

object_name: Headache, CTCAE


subject: CHEBI:85196

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:85196

object_name: Fatigue


subject: CHEBI:85196

object_name: Myalgia, CTCAE


subject: CHEBI:85196

object_name: Myalgia


subject: CHEBI:85196

object_name: Cough


subject: CHEBI:85196

object_name: Cough, CTCAE


subject: CHEBI:85202

subject_name: Peramivir


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: CHEBI:85202


subject: UMLS:C0541491

subject_name: Drugs and Biologicals

object_name: atopic eczema


subject: UMLS:C1328819

subject_name: Small Molecule


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: hypotension


subject: UMLS:C0521942

object_name: Hypotension, CTCAE


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:9831414

object_name: peripheral arterial disease


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:6ST3ZF52WB

subject_name: Carboxyamidotriazole

object_name: Stage IV Renal Cell Cancer


subject: UNII:6ST3ZF52WB

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:6ST3ZF52WB

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:6ST3ZF52WB

object_name: Renal cell carcinoma recurrent


subject: UNII:6ST3ZF52WB

object_name: Renal cancer recurrent


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: dermatitis


subject: UNII:FYS6T7F842

object_name: Dermatitis


subject: UNII:FYS6T7F842

object_name: allergic contact dermatitis


subject: PUBCHEM.COMPOUND:578771

subject_name: Betamethasone 17 Valerate


subject: PUBCHEM.COMPOUND:578771


subject: PUBCHEM.COMPOUND:578771


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: CHEBI:3077


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: UNII:37CQ2C7X93


subject: UNII:37CQ2C7X93


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UNII:420K487FSG

subject_name: Dupilumab


subject: UNII:420K487FSG


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134


subject: CHEBI:5134


subject: UNII:089658A12D

subject_name: Guselkumab


subject: UNII:089658A12D


subject: UNII:089658A12D


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: CHEBI:53612

subject_name: Squaric acid dibutyl ester


subject: CHEBI:53612


subject: CHEBI:53612


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: UNII:FU77B4U5Z0


subject: UNII:FU77B4U5Z0


subject: UMLS:C5556784

subject_name: PSMA/FRa Bispecific Peptide-drug Conjugate CBP-1018

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556784

object_name: Adult Solid Neoplasm


subject: UMLS:C5556784

object_name: Solid Neoplasm


subject: UNII:G6S5600O0D

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:G6S5600O0D

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:G6S5600O0D

object_name: refractory anemia with excess blasts in transformation


subject: UNII:G6S5600O0D

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:G6S5600O0D

object_name: Blast Phase


subject: UNII:G6S5600O0D

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:G6S5600O0D

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UNII:G6S5600O0D

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UNII:G6S5600O0D

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:G6S5600O0D

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:G6S5600O0D

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:G6S5600O0D

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:G6S5600O0D

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:G6S5600O0D

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:G6S5600O0D

object_name: recurrent adult acute myeloid leukemia


subject: UNII:G6S5600O0D

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:G6S5600O0D

object_name: acute megakaryoblastic leukemia in adult


subject: UNII:G6S5600O0D

object_name: Chronic lymphocytic leukaemia stage 3


subject: UNII:G6S5600O0D

object_name: Adult Acute Myelomonocytic Leukemia


subject: UNII:G6S5600O0D

object_name: Chronic lymphocytic leukaemia stage 4


subject: UNII:G6S5600O0D

object_name: Adult Acute Monoblastic Leukemia


subject: UNII:G6S5600O0D

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:G6S5600O0D

object_name: juvenile myelomonocytic leukemia


subject: UNII:G6S5600O0D

object_name: chronic myelomonocytic leukemia


subject: UNII:G6S5600O0D

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:G6S5600O0D

object_name: adult acute monocytic leukemia


subject: UNII:G6S5600O0D

object_name: Adult Acute Eosinophilic Leukemia


subject: UNII:G6S5600O0D

object_name: Adult Pure Erythroid Leukemia


subject: UNII:G6S5600O0D

object_name: Adult Acute Basophilic Leukemia


subject: UNII:G6S5600O0D

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: hepatobiliary neoplasm


subject: CHEBI:80961

object_name: cholangiocarcinoma


subject: CHEBI:80961

object_name: liver cancer


subject: CHEBI:80961

object_name: liver neoplasm


subject: CHEBI:80961

object_name: Adult Liver Carcinoma


subject: CHEBI:80961

object_name: liver carcinoma


subject: CHEBI:80961

object_name: gallbladder cancer


subject: CHEBI:80961

object_name: gallbladder carcinoma


subject: CHEBI:80961


subject: CHEBI:80961

object_name: bile duct carcinoma


subject: CHEBI:80961

object_name: bile duct cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:229526

subject_name: Sparsentan

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEBI:229526

object_name: immune system disorder


subject: CHEBI:229526

object_name: Autoimmunity


subject: CHEBI:229526

object_name: glomerulonephritis


subject: CHEBI:229526

object_name: kidney disorder


subject: CHEBI:50673

subject_name: Methimazole

object_name: substance withdrawal syndrome


subject: CHEBI:50673

object_name: Drug withdrawal syndrome


subject: CHEBI:50673

object_name: Recurrent disease


subject: CHEBI:50673

object_name: Global Relapse in Viscera


subject: CHEBI:50673

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:50673

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:50673

object_name: Global Relapse


subject: CHEBI:50673

object_name: Global Relapse in Skin


subject: CHEBI:50673

object_name: Global Relapse in Blood


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:92002593

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: UNII:4Q52C550XK


subject: UNII:4Q52C550XK


subject: UMLS:C2954669

subject_name: diosmiplex

object_name: Lipedema


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Adenocarcinoma of lung, stage I


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: bowel dysfunction


subject: PUBCHEM.COMPOUND:74030550

object_name: intestinal disorder


subject: CHEBI:4911

subject_name: Etoposide

object_name: Blast Phase


subject: CHEBI:4911

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4911

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:70707

subject_name: Vilazodone

object_name: generalized anxiety disorder


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Parkinson disease


subject: UMLS:C0719635

subject_name: DOS brand of docusate sodium

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:132042903

subject_name: balinatunfib

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:132042903

object_name: ulcerative colitis


subject: UNII:PLY98MAN4C

subject_name: BALINATUNFIB


subject: UNII:PLY98MAN4C


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: chronic disease


subject: MESH:D004043

object_name: Chronic Disease


subject: CHEBI:233197

subject_name: devimistat

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:233197

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:233197

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:233197

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:233197

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:233197

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:233197

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:233197

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:233197

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:233197

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:233197

object_name: stage IV pancreatic cancer


subject: CHEBI:233197

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:233197

object_name: Refractory Urothelial Carcinoma


subject: CHEBI:233197

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:233197

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:233197

object_name: Refractory Lung Adenocarcinoma


subject: CHEBI:233197

object_name: Refractory Biliary Tract Carcinoma


subject: CHEBI:233197

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:233197

object_name: Advanced Lung Adenocarcinoma


subject: CHEBI:233197

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:233197

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:233197

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:233197

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:233197

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:233197

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:233197

object_name: Metastatic urothelial carcinoma


subject: CHEBI:233197

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:233197

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:233197

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:233197

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:233197

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:233197

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:233197

object_name: Metastatic Biliary Tract Carcinoma


subject: CHEBI:233197

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:233197

object_name: Metastatic Lung Adenocarcinoma


subject: UNII:E76113IR49

subject_name: Devimistat

object_name: Refractory Colorectal Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Colorectal Carcinoma


subject: UNII:E76113IR49

object_name: Refractory Pancreatic Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Pancreatic Carcinoma


subject: UNII:E76113IR49

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Metastatic Colorectal Carcinoma


subject: UNII:E76113IR49

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:E76113IR49

object_name: stage IV pancreatic cancer


subject: UNII:E76113IR49

object_name: Refractory Ovarian Carcinoma


subject: UNII:E76113IR49

object_name: Refractory Urothelial Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Ovarian Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:E76113IR49

object_name: Refractory Lung Adenocarcinoma


subject: UNII:E76113IR49

object_name: Refractory Biliary Tract Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Urothelial Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Lung Adenocarcinoma


subject: UNII:E76113IR49

object_name: Advanced Biliary Tract Carcinoma


subject: UNII:E76113IR49

object_name: Advanced Bile Duct Carcinoma


subject: UNII:E76113IR49

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: UNII:E76113IR49

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:E76113IR49

object_name: Stage III Ovarian Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Metastatic urothelial carcinoma


subject: UNII:E76113IR49

object_name: Stage IV Ovarian Carcinoma


subject: UNII:E76113IR49

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:E76113IR49

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:E76113IR49

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:E76113IR49

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:E76113IR49

object_name: Metastatic Biliary Tract Carcinoma


subject: UNII:E76113IR49

object_name: Metastatic Bile Duct Carcinoma


subject: UNII:E76113IR49

object_name: Metastatic Lung Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Refractory Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Pancreatic Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Advanced Pancreatic Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Urothelial Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Advanced Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Lung Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Biliary Tract Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Advanced Urothelial Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Advanced Lung Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Advanced Biliary Tract Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic urothelial carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Biliary Tract Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Lung Adenocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:46345

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:46345

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:46345

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:46345

object_name: Refractory Urothelial Carcinoma


subject: CHEBI:46345

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:46345

object_name: Refractory Lung Adenocarcinoma


subject: CHEBI:46345

object_name: Refractory Biliary Tract Carcinoma


subject: CHEBI:46345

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:46345

object_name: Advanced Lung Adenocarcinoma


subject: CHEBI:46345

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:46345

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:46345

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:46345

object_name: Metastatic urothelial carcinoma


subject: CHEBI:46345

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:46345

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:46345

object_name: Metastatic Biliary Tract Carcinoma


subject: CHEBI:46345

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:46345

object_name: Metastatic Lung Adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:175901

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:175901

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:175901

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:175901

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:175901

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:175901

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:175901

object_name: Refractory Urothelial Carcinoma


subject: CHEBI:175901

object_name: Refractory Lung Adenocarcinoma


subject: CHEBI:175901

object_name: Refractory Biliary Tract Carcinoma


subject: CHEBI:175901

object_name: Advanced Lung Adenocarcinoma


subject: CHEBI:175901

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:175901

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:175901

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:175901

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:175901

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:175901

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:175901

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:175901

object_name: Metastatic Lung Adenocarcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:5801

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:5801

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:5801

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:5801

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:5801

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:5801

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:5801

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:5801

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:5801

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:5801

object_name: stage IV pancreatic cancer


subject: CHEBI:5801

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:5801

object_name: Refractory Urothelial Carcinoma


subject: CHEBI:5801

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:5801

object_name: Refractory Lung Adenocarcinoma


subject: CHEBI:5801

object_name: Refractory Biliary Tract Carcinoma


subject: CHEBI:5801

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:5801

object_name: Advanced Lung Adenocarcinoma


subject: CHEBI:5801

object_name: Advanced Biliary Tract Carcinoma


subject: CHEBI:5801

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:5801

object_name: Refractory Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:5801

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:5801

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:5801

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:5801

object_name: Metastatic urothelial carcinoma


subject: CHEBI:5801

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:5801

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:5801

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:5801

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:5801

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:5801

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:5801

object_name: Metastatic Biliary Tract Carcinoma


subject: CHEBI:5801

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:5801

object_name: Metastatic Lung Adenocarcinoma


subject: PUBCHEM.COMPOUND:146195299

subject_name: Golcadomide

object_name: large B-cell lymphoma


subject: UNII:29HLR8Z5BR

subject_name: GOLCADOMIDE


subject: UNII:PE952ANF83

subject_name: Uproleselan

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:4358571

subject_name: Valspodar

object_name: leukemia


subject: PUBCHEM.COMPOUND:4358571

object_name: childhood leukemia


subject: CHEBI:63451

subject_name: Infigratinib

object_name: glioma


subject: CHEBI:63451

object_name: malignant glioma


subject: CHEBI:63451

object_name: glioblastoma


subject: CHEBI:63451

object_name: Childhood Glioblastoma


subject: CHEBI:63451

object_name: adult glioblastoma


subject: CHEBI:63631

subject_name: Topiramate

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:63631

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:63631

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:66624888

subject_name: Remodulin

object_name: peripheral vascular disease


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: cocaine abuse


subject: UNII:618SLL9VBS

subject_name: Omiganan

object_name: seborrheic dermatitis


subject: UMLS:C4550028


subject: UMLS:C2715577

object_name: lichen planus


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Solid Neoplasm


subject: GTOPDB:10492

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:10492

object_name: clear cell renal carcinoma


subject: GTOPDB:10492

object_name: renal cell adenocarcinoma


subject: GTOPDB:10492

object_name: renal cell carcinoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C1704263

subject_name: green tea extract

object_name: skin neoplasm


subject: UMLS:C1704263

object_name: skin cancer


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Xerostomia


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:9916099

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:9916099

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:9916099

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:9916099

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:9916099

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:9916099

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:9916099

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:9916099

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:9916099

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:9916099

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:9916099

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:9916099

object_name: lymphoblastic lymphoma